MEDIVIR AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.24 SEK | +6.23% |
|
+21.35% | +13.68% |
| Apr. 25 | Medivir Gets Two US FDA Designations for MIV-711 | MT |
| Mar. 21 | Certain Shares of Medivir AB are subject to a Lock-Up Agreement Ending on 21-MAR-2024. | CI |
Evolution of the average Target Price on Medivir AB
Price target over the last 5 years
History of analyst recommendation changes
b78861cf884111169.kA9mVAQxHpYks6R1odHqrsmdP8gSXF6N3896dAu0Ilk.50w-EHAJUMx9wpAdxqCP8aD6DrJ-BirMuogbFTLCRzLCQgcyYVtX007hxw~28905f25807446760cdacb3103e7e4f6
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
3.24
SEK
Average target price
20.55
SEK
Spread / Average Target
+534.39%
High Price Target
54
SEK
Spread / Highest target
+1,566.67%
Low Price Target
7.75
SEK
Spread / Lowest Target
+139.20%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
- Stock Market
- Equities
- MVIR B Stock
- Consensus Medivir AB
